Wegovy FlexTouch 0.25mg (1 pen = 4 doses) – PREORDER

This product is available for pre-order only. Once your order is placed, we will procure the item directly from our supplier. Delivery may take additional time depending on availability. You will be notified via email with updates.

Wegovy FlexTouch 0.25mg is an innovative prescription medication designed for long-term weight management, containing the active ingredient semaglutide, a GLP-1 receptor agonist approved by the FDA. This hormone-like compound works by reducing appetite, slowing gastric emptying, and improving control over eating behavior — making it a highly effective tool in the treatment of obesity and overweight conditions.

Each pre-filled pen provides 4 weekly doses of 0.25mg, formulated specifically for the initiation phase of Wegovy therapy. The low starting dose is used to help patients adjust to the medication and minimize gastrointestinal side effects before gradually increasing the dosage.

The standard Wegovy treatment protocol follows a titration schedule:

• Weeks 1–4: 0.25mg once weekly

• Weeks 5–8: 0.5mg once weekly

• Weeks 9–12: 1mg once weekly

• Weeks 13–16: 1.7mg once weekly

• Week 17 and onward: 2.4mg once weekly (maintenance dose)

This progressive increase supports better tolerability and long-term treatment adherence. The FlexTouch pen ensures accurate, pre-measured dosing and ease of use for self-injection.

Must be used under the supervision of a healthcare professional.